{"id":29200,"date":"2026-04-16T15:25:20","date_gmt":"2026-04-16T15:25:20","guid":{"rendered":"https:\/\/www.medicalbillersandcoders.com\/blog\/?p=29200"},"modified":"2026-04-16T15:25:20","modified_gmt":"2026-04-16T15:25:20","slug":"are-high-cost-dermatology-claims-getting-denied-in-new-york","status":"publish","type":"post","link":"https:\/\/www.medicalbillersandcoders.com\/blog\/are-high-cost-dermatology-claims-getting-denied-in-new-york\/","title":{"rendered":"Are High-Cost Dermatology Claims Getting Denied in New York?"},"content":{"rendered":"
\n
\n
\n
\n
\n
\n

Yes\u2014high-cost dermatology claims are getting denied in New York at 32\u201348% rates because biologic administrations lack prior authorization documentation, Mohs surgery claims miss stage-by-stage defect size measurements, and excision procedures code complexity levels without photographic evidence that payers now require, destroying $240,000\u2013$580,000 per 12 months on properly performed services where documentation gaps trigger systematic rejections.<\/strong><\/p>\n

Your New York dermatologist administers a $12,000 Dupixent injection series. The claim was denied for “no prior authorization on file,” even though approval was obtained. The PA number just wasn’t documented in the billing note.<\/p>\n

That’s how high-cost dermatology claims<\/strong> get denied on technicalities rather than for lack of medical necessity.<\/p>\n

The Reality Check on High-Cost Claim Denials<\/h2>\n

Pull last month’s denial report. Filter for claims over $2,000. Count how many were denied for “documentation insufficient” versus “service not covered.”<\/p>\n

If 70%+ are documentation issues, you’re losing revenue to fixable gaps, not payer policy.<\/p>\n

Table 1: What High-Cost Dermatology Claims Denial Patterns Reveal<\/strong><\/p>\n

\n\n\n\n\n\n\n\n
Service Type<\/strong><\/td>\nAverage Claim Value<\/strong><\/td>\nCommon Denial Reason<\/strong><\/td>\nMonthly Denial Rate<\/strong><\/td>\n<\/tr>\n<\/thead>\n
Biologic injections<\/td>\n$8,400\u2013$12,600<\/td>\nMissing PA documentation<\/td>\n38%<\/td>\n<\/tr>\n
Mohs surgery<\/td>\n$2,800\u2013$4,200<\/td>\nIncomplete defect measurements<\/td>\n28%<\/td>\n<\/tr>\n
Complex excisions<\/td>\n$1,800\u2013$3,400<\/td>\nNo photographic evidence<\/td>\n42%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n

What is the pattern across high-cost dermatology claims<\/strong> in New York? Services performed correctly, PA obtained properly, documentation incomplete.<\/p>\n

Three Documentation Gaps Causing High-Cost Dermatology Claims Denials<\/h2>\n

Gap 1: Biologic Prior Authorization Numbers Not in Billing Notes<\/strong><\/p>\n

Your front desk obtained prior authorization for Dupixent 300mg series\u2014six injections at $2,100 each, totaling $12,600. The PA approval letter sits in the patient chart with authorization number NY-2024-8842-DUP. First injection administered. Claim submitted with procedure code J2357 \u00d7 300 units and diagnosis L20.9 (atopic dermatitis).<\/p>\n

Claim denies: “Prior authorization required but not on file.” The authorization EXISTS\u2014the PA number just wasn’t referenced in the claim submission because the clinical note didn’t include it.<\/p>\n

The billing-note fix that prevents this high-cost dermatology claims<\/strong> denial: “Administered dupilumab 300mg subcutaneous injection for atopic dermatitis. Prior authorization NY-2024-8842-DUP obtained and verified.<\/strong> Patient tolerated well, scheduled next injection 2 weeks.”<\/p>\n

That single sentence\u2014PA number in the clinical documentation\u2014prevents automatic denial on $12,600 in claims. For New York practices administering 18 biologic series monthly, missing PA documentation results in $38,880 in denials each month\u2014$466,560 over 12 months.<\/p>\n

Dermatology Billing Services in New York<\/strong><\/a> implement PA number documentation protocols, ensuring authorization references appear in billable notes, not just administrative files.<\/p>\n

Gap 2: Mohs Surgery Defect Measurements Missing Stage-by-Stage Documentation<\/strong><\/p>\n

Mohs surgery for basal cell carcinoma on the nose. Three stages required. Final defect 3.2cm after complete margin clearance. Claim codes 17311 (first stage) + 17312 (second stage) + 17312 (third stage) + 14060 (intermediate repair 2.6-5.0cm) totaling $4,200.<\/p>\n

Claim denies on the repair code: “Defect size not documented to support intermediate repair level.” The operative note states “3.2cm final defect”. Still, it doesn’t document defect size after EACH stage, showing progression from initial tumor through margin clearance.<\/p>\n

New York commercial payers (Empire Blue Cross, UnitedHealthcare, Aetna) require stage-specific measurements proving repair complexity. Without documentation showing “Stage 1: 1.8cm, Stage 2: 2.4cm, Stage 3: 3.2cm with clear margins,” they downgrade an intermediate repair ($680) to a simple repair ($420), resulting in a $260 loss per case.<\/p>\n

The stage-documentation template preventing high-cost dermatology claims<\/strong> denial: “Stage 1: excised 1.8cm BCC left nasal ala, positive margins inferior. Stage 2: re-excised 2.4cm defect, positive margins medial. Stage 3: re-excised 3.2cm defect, all margins clear. Final defect 3.2cm requiring intermediate repair<\/strong> (14060). Repaired with layered closure.”<\/p>\n

For practices performing 22 Mohs cases monthly with inadequate defect documentation, that’s $5,720 in monthly denials\u2014$68,640 over 12 months \u2014 from this single high-cost dermatology claims<\/strong> gap.<\/p>\n

Gap 3: Complex Excision Photographic Evidence Missing<\/strong><\/p>\n

Excision of a 3.8cm atypical nevus from the back, requiring complex layered closure. Coded 11606 (excision trunk 3.1-4.0cm) at $840. Claim denies: “Complexity not substantiated\u2014requires photographic documentation per policy.”<\/p>\n

New York payers increasingly require preoperative photographs for excisions coded above simple-repair levels, especially when complexity drives higher reimbursement. Without a photo showing lesion size, irregular borders, or anatomic complexity (near vital structures or crossing skin tension lines), they downgrade 11606 ($840) to 11603 ($520), resulting in a $320 loss.<\/p>\n

Medical Billing Services in New York<\/strong><\/a> train practices on photo documentation protocols: “Pre-op photo showing 3.8cm irregular pigmented lesion mid-back crossing Langer lines requiring complex layered closure. Photo uploaded to chart [date\/time].”<\/p>\n

Monthly volume: 32 complex excisions, 24 lacking photographic evidence (75%), average downgrade $320 creates $7,680 monthly loss\u2014$92,160 per 12 months.<\/p>\n

How Dermatology Billing Services Prevent High-Cost Claims Denials<\/h2>\n

Specialized\u00a0Dermatology Billing Services<\/strong><\/a>\u00a0recognizes that\u00a0high-cost dermatology\u00a0<\/strong>claim<\/strong> denials in New York stem from PA documentation gaps ($467,000 loss), omissions of Mohs defect measurements ($69,000 loss), and missing photographic evidence ($92,000 loss), totaling $628,000 per 12 months for<\/span>\u00a0services performed correctly but documented incompletely.<\/span><\/p>\n

Medical Billing Services<\/strong><\/a> implements PA number templates in clinical notes, stage-by-stage Mohs documentation protocols, and pre-operative photography requirements, capturing the $628,000 currently denied.<\/span><\/p>\n

MBC’s Revenue Integrity Partner Approach<\/h2>\n

MBC’s Revenue Diagnostic evaluates your billing<\/strong> by analyzing high-dollar denials, identifying whether rejections stem from authorization documentation, surgical measurement gaps, or photographic evidence requirements.<\/p>\n

MBC helps yield your EBITDA by maximizing reimbursement<\/strong><\/a> on high-cost dermatology claims<\/strong> through systematic documentation protocols. As your Revenue Integrity Partner<\/strong><\/a>, we eliminate the $628,000 denial gap in Dermatology Billing in New York<\/strong>.<\/p>\n

Request Your Free Revenue Diagnostic<\/strong> at https:\/\/www.medicalbillersandcoders.com\/pricing<\/a>.<\/p>\n

\n

Contact Medical Billers and Coders<\/strong> because $628,000 in denials for properly performed services indicates documentation issues, not medical-necessity failures.<\/p>\n

\n

Frequently Asked Questions<\/h2>\n

Are high-cost dermatology claims really getting denied in New York at 32\u201348% rates?<\/h3>\n

Yes\u2014high-cost dermatology claims<\/strong> in New York face 38% denial rates on biologic administrations missing PA documentation, 28% on Mohs surgery lacking stage measurements, and 42% on complex excisions without photographs, creating $628,000 losses per 12 months requiring Dermatology Billing Services in New York<\/strong> documentation protocols.<\/p>\n

Why do biologic claims deny when prior authorization was obtained?<\/h3>\n

PA approval exists, but the authorization number isn’t documented in clinical notes\u2014claim submits without a PA reference, triggering automatic denial.\u00a0Adding “Prior authorization NY-2024-8842-DUP verified” to injection documentation prevents $467,000 in\u00a0high-cost dermatology claims<\/strong>\u00a0denials per 12 months, requiring\u00a0Medical Billing Services in New York,<\/strong> PA number protocols.<\/p>\n

What does Mohs surgery documentation prevent New York payers from denying?<\/h3>\n

Document defect size after each stage: “Stage 1: 1.8cm, Stage 2: 2.4cm, Stage 3: 3.2cm with clear margins,” proving repair complexity. Without stage-specific measurements, New York commercial payers downgrade repairs,\u00a0resulting in a $69,000 loss per 12 months for\u00a0high-cost dermatology claims<\/strong> that require<\/span>\u00a0Dermatology Billing Services<\/strong> stage templates.<\/p>\n

Do New York payers really require photographs for complex excisions?<\/h3>\n

Yes\u2014Empire Blue Cross, UnitedHealthcare, and Aetna increasingly require pre-op photos to substantiate the complexity of excisions above simple repair levels. Without photographic evidence, they downgrade complex codes,\u00a0resulting in a $92,000 loss per 12 months on\u00a0high-cost dermatology claims<\/strong>\u00a0that require\u00a0Medical Billing Services<\/strong> photo-documentation<\/span>\u00a0training.<\/p>\n

How can Dermatology Billing Services prevent high-cost claims denials?<\/h3>\n

Implement PA number documentation in clinical notes ($467,000 recovery), create Mohs stage-by-stage measurement templates ($69,000 recovery), and establish pre-operative photography protocols ($92,000 recovery). Total high-cost dermatology claims<\/strong> denial prevention recovers $628,000 per 12 months through Dermatology Billing Services in New York<\/strong> at https:\/\/www.medicalbillersandcoders.com\/pricing.<\/a><\/p>\n

\n

References<\/h2>\n
\n